Skip to main content
. 2013 Apr 18;76(6):888–896. doi: 10.1111/bcp.12129

Figure 3.

Figure 3

Effect–time profiles of the mean (and SD) change from baseline (%) for total lymphocyte count after single-dose administration of placebo (n = 12) or ponesimod at doses of 1, 3, 8, 20, 50 or 75 mg (n = 6 per dose group). Inline graphic, 1 mg; Inline graphic, 3 mg; Inline graphic, 8 mg; Inline graphic, 20 mg; Inline graphic, 50 mg; Inline graphic, 75 mg; Inline graphic, placebo